Kinetensin
CAS No. 103131-69-7
Kinetensin( Kinetensin (human) )
Catalog No. M29815 CAS No. 103131-69-7
Kinetensin is a neurotensin-like peptide.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 133 | Get Quote |
|
| 10MG | 214 | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
Biological Information
-
Product NameKinetensin
-
NoteResearch use only, not for human use.
-
Brief DescriptionKinetensin is a neurotensin-like peptide.
-
DescriptionKinetensin is a neurotensin-like peptide.(In Vitro):The peptide kinetensin isolated from pepsin-treated human plasma induces a dose-dependent release of histamine when exposed to rat peritoneal mast cells. The threshold concentration is around 1 μM, the ED50 is 10 μM, and the optimal concentration of between 100 to 1000 μM released 80% of the total histamine. Kinetensin is 10 to 100 times less potent than neurotensin and equipotent with the opioid peptide dynorphin. The histamine release is clearly temperature-dependent, with no release occurring at 0 or 45 °C and with an optimum around 37 °C. The histamine release is significantly reduced in the absence of extracellular calcium.(In Vivo):Kinetensin also induces a dose-dependent increase in vascular permeability when injected intradermally into rats.
-
In VitroThe peptide kinetensin isolated from pepsin-treated human plasma induces a dose-dependent release of histamine when exposed to rat peritoneal mast cells. The threshold concentration is around 1 μM, the ED50 is 10 μM, and the optimal concentration of between 100 to 1000 μM released 80% of the total histamine. Kinetensin is 10 to 100 times less potent than neurotensin and equipotent with the opioid peptide dynorphin. The histamine release is clearly temperature-dependent, with no release occurring at 0 or 45 °C and with an optimum around 37 °C. The histamine release is significantly reduced in the absence of extracellular calcium.
-
In VivoKinetensin also induces a dose-dependent increase in vascular permeability when injected intradermally into rats.
-
SynonymsKinetensin (human)
-
PathwayOthers
-
TargetOther Targets
-
RecptorNeurotensin Receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number103131-69-7
-
Formula Weight1172.38
-
Molecular FormulaC56H85N17O11
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (85.30 mM)
-
SMILES——
-
Chemical NameSequence:Ile-Ala-Arg-Arg-His-Pro-Tyr-Phe-Leu
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
Mogard MH, et al. The amino acid sequence of kinetensin, a novel peptide isolated from pepsin-treated human plasma: homology with human serum albumin, neurotensin and angiotensin. Biochem Biophys Res Commun. 1986 May 14;136(3):983-8.
molnova catalog
related products
-
AVP-13358
AVP-13358 is a CD23 antagonist (immunoglobulin ε-Fc receptor antagonist), an immunoglobulin E inhibitor.
-
AP39 Free base
AP39 free base is a mitochondrial-targeted H(2)S donor that can improve the survival rate of porcine islets in culture.
-
Glycerol Tridecanoat...
Glycerol Tridecanoate is also known as triacylglycerols or triacylglycerides. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins which deliver the fatty acids to and from fat cells among other functions. Various tissues can release free fatty acids and take them up as a source of energy.
Cart
sales@molnova.com